Palonosetron

🧮 Dose calculator

Chemotherapy-induced nausea and vomiting · Regimen source: FDA Palonosetron · 2.1, Table 1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Palonosetron · 8.1

  “Risk Summary There are no available data on palonosetron HCl use in pregnant women to inform a drug-associated risk.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Palonosetron · 8.2

  “Risk Summary There are no data on the presence of palonosetron in human milk, the effects of palonosetron on the breastfed infant, or the effects of palonosetron on milk production.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Palonosetron · 8.4

  “Chemotherapy-Induced Nausea and Vomiting Safety and effectiveness of palonosetron hydrochloride injection have been established in pediatric patients aged 1 month to less than 17 years for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, …”

• 👴 Older adultsNo specific problem stated

  Label: no specific difference or dose adjustment stated for older adults. FDA Palonosetron · 8.5

  “No dose adjustment is required for geriatric patients.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.